ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in February 2025. Updated on February 20, 2025.
A roundup of FDA’s actions in February 2025.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in February 2025. Updated on February 20, 2025.
A roundup of FDA’s actions in February 2025.